Cargando…
Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis
Inflammatory bowel disease increases the risk of developing colon cancer. Interleukin (IL-) 37 is a fundamental inhibitor of innate immunity by reducing systemic and local inflammation. IL-37 protein is expressed in healthy and diseased bowel and liver tissue. Here, we tested whether transgenic expr...
Autores principales: | Mountford, Steffeni, Ringleb, Andrea, Schwaiger, Rahel, Mayr, Doris, Kobold, Sebastian, Dinarello, Charles A., Bufler, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857648/ https://www.ncbi.nlm.nih.gov/pubmed/31781119 http://dx.doi.org/10.3389/fimmu.2019.02632 |
Ejemplares similares
-
Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021) -
Interleukin 37 is a fundamental inhibitor of innate immunity
por: Nold, Marcel F, et al.
Publicado: (2010) -
In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced Hepatitis
por: Bulau, Ana-Maria, et al.
Publicado: (2011) -
Interleukin-37 as fundamental inhibitor of innate immunity
por: Bufler, P
Publicado: (2011) -
Methods for Carcinogensis Tests at the Cellular Level and Their Evaluation for the Assessment of Occupational Cancer Hazards
por: Fox, M.
Publicado: (1979)